
Validea's guru fundamental report assigns Accenture PLC (ACN) a 92% rating on its Warren Buffett-inspired 'Patient Investor' model, indicating strong alignment with criteria for long-term, predictable profitability and reasonable valuation. The large-cap computer services firm passes key fundamental tests including earnings predictability, debt service, free cash flow, and return on equity, suggesting it meets the stringent requirements of a value-oriented, long-term investment strategy.
Accenture PLC (ACN) has received a highly favorable assessment based on Validea's 'Patient Investor' model, which quantitatively applies Warren Buffett's investment principles. The company scored 92%, a rating that signifies strong interest from the model, as it exceeds the 90% threshold for this designation. This strong rating is underpinned by ACN's robust performance across several fundamental criteria, where it passed tests for earnings predictability, debt service, return on equity, return on total capital, and free cash flow generation. These results indicate a company with long-term, predictable profitability and a healthy balance sheet. The analysis also positively rates Accenture's use of retained earnings and its expected rate of return. The only criterion not receiving a full 'PASS' was share repurchases, which was deemed 'NEUTRAL,' suggesting this aspect of its capital allocation is adequate but not a standout strength according to the model's specific tests.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.85
Ticker Sentiment